期刊
JOURNAL OF CLINICAL INVESTIGATION
卷 124, 期 5, 页码 2071-2075出版社
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI73186
关键词
-
资金
- Legacy Heritage Biomedical Program of the Israel Science Foundation [1531/2009]
- US Agency for International Development (USAID) program for Middle East Regional Cooperation [TA-MOU-10-M30-021]
The transcription factor steroidogenic factor 1 (SF-1; also known as NR5A1) is a crucial mediator of both steroidogenic and nonsteroidogenic tissue differentiation. Mutations within SF1 underlie different disorders of sexual development (DSD), including sex reversal, spermatogenic failure, ovarian insufficiency, and adrenocortical deficiency. Here, we identified a recessive mutation within SF1 that resulted in a substitution of arginine to glutamine at codon 103 (R103Q) in a child with both severe 46,XY-DSD and asplenia. The R103Q mutation decreased SF-1 transactivation of TLX1, a transcription factor that has been shown to be essential for murine spleen development. Additionally, the SF1 R103Q mutation impaired activation of steroidogenic genes, without affecting synergistic SF-1 and sex-determining region Y (SRY) coactivation of the testis development gene SOX9. Together, our data provide evidence that SF-1 is required for spleen development in humans via transactivation of TLX1 and that mutations that only impair steroid.ogenesis, without altering the SF1/SRY transactivation of SOX9, can lead to 46,XY-DSD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据